This is the first conference of this kind and aimed at health care professionals, who would like to increase their knowledge in lipid disorders.
Lipid disorders remain amongst the most important treatable risk factors for cardiovascular diseases. While we have better and better drugs available to treat dyslipidemias, residual risk remains and many patients do not reach their targets.
This conference aims to deal with all aspects of lipid disorders from diagnosis to treatment, from diet to novel lipid lowering drugs, from adverse events to compliance issues.
Current and future lipid lowering therapies will be discussed in plenary lectures and small workshops by world leaders in lipidology.
Leading clinicians from around the world will contribute to a cutting edge program that aims to capture the scope and depth of the exciting field of lipidology.